UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα

Annals of the rheumatic diseases, 2008-09, Vol.67 (9), p.1332-1338

2008

Volltextzugriff (PDF)

Adjuvants — a balance between toxicity and adjuvanticity

Vaccine, 1993, Vol.11 (3), p.293-306

1993

Volltextzugriff (PDF)

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases

Cytokine & growth factor reviews, 2003-04, Vol.14 (2), p.123-137

2003

Volltextzugriff (PDF)

Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use

Biomedicine & pharmacotherapy, 2000-02, Vol.54 (1), p.41-44

2000

Volltextzugriff (PDF)

Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC)

Biomedicine & pharmacotherapy, 1998-01, Vol.52 (10), p.436-439

1998

Volltextzugriff (PDF)

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes

Biomedicine & pharmacotherapy, 1999-10, Vol.53 (9), p.424-431

1999

Volltextzugriff (PDF)

Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes

Biomedicine & pharmacotherapy, 2001-07, Vol.55 (6), p.316-320

2001

Volltextzugriff (PDF)

Vaccination with Tat Toxoid Attenuates Disease in Simian/HIV-Challenged Macaques

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3515-3519

2000

Volltextzugriff (PDF)

Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3515-3519

2000

Volltextzugriff (PDF)

"Kinoids": the basis for anticytokine immunization and their use in HIV infection

Cellular and molecular biology (Noisy-le-Grand, France), 1995-05, Vol.41 (3), p.351

1995

Volltextzugriff (PDF)

Preparation of diphtheria vaccines using highly purified toxins

Vaccine, 1997-03, Vol.15 (4), p.459-460

1997

Volltextzugriff (PDF)

Interferon α and Tat Involvement in the Immunosuppression of Uninfected T Cells and C-C Chemokine Decline in AIDS

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (7), p.3851-3856

1998

Volltextzugriff (PDF)

C-C Chemokines, Pivotal in Protection against HIV Type 1 Infection

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (7), p.3857-3861

1998

Volltextzugriff (PDF)

Contribution of alpha interferon (alpha IFN) to HIV-induced immunosuppression

Cellular and molecular biology (Noisy-le-Grand, France), 1995-05, Vol.41 (3), p.431

1995

Volltextzugriff (PDF)

Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients

Journal of human virology, 1998-05, Vol.1 (4), p.293

1998

Volltextzugriff (PDF)

Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals

Biomedicine & pharmacotherapy, 1997-01, Vol.51 (10), p.427-429

1997

Volltextzugriff (PDF)

Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia

Biomedicine & pharmacotherapy, 2000-06, Vol.54 (5), p.268-273

2000

Volltextzugriff (PDF)

IFNα kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS

Biomedicine & pharmacotherapy, 1999-03, Vol.53 (2), p.87-89

1999

Volltextzugriff (PDF)

Involvement of α-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment

Biomedicine & pharmacotherapy, 1994, Vol.48 (2), p.73-77

1994

Volltextzugriff (PDF)

Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein

Biomedicine & pharmacotherapy, 1999-08, Vol.53 (7), p.323-328

1999

Volltextzugriff (PDF)

Production in rabbits of high levels of anti-HIV-1 gp160 antibodies

Cellular and molecular biology (Noisy-le-Grand, France), 1995-05, Vol.41 (3), p.389

1995

Volltextzugriff (PDF)

Anti-IFNα immunization raises the IFNα-neutralizing capacity of serum — an adjuvant to antiretroviral tritherapy

Biomedicine & pharmacotherapy, 1999-03, Vol.53 (2), p.90-92

1999

Volltextzugriff (PDF)

Identification of CD4 and Major Histocompatibility Complex Functional Peptide Sites and Their Homology with Oligopeptides from Human Immunodeficiency Virus Type 1 Glycoprotein gp120: Role in AIDS Pathogenesis

Proceedings of the National Academy of Sciences - PNAS, 1993-08, Vol.90 (16), p.7573-7577

1993

Volltextzugriff (PDF)

Early and long-lasting protection from arthritis in tumour necrosis factor (TNF ) transgenic mice vaccinated against TNF

Annals of the rheumatic diseases, 2008-09, Vol.67 (9), p.1332-1338

2008

Volltextzugriff (PDF)

Lectin production by human T-lymphocytes

Biomedicine & pharmacotherapy, 1999-06, Vol.53 (5), p.288-289

1999

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(113)
Animals
(97)
Humans
(95)
Biological And Medical Sciences
(72)
Female
(53)
Mice
(46)
Male
(39)
Medical Sciences
(39)
Aids/hiv
(36)
Microbiology
(36)
Pharmacology & Pharmacy
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)
Medicine, Research & Experimental
(30)
Research & Experimental Medicine
(30)
Adult
(28)
Middle Aged
(27)
Immunology
(25)
Rats
(24)
Vaccination
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα

Adjuvants — a balance between toxicity and adjuvanticity

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases

Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use

Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC)

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes

Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes

Vaccination with Tat Toxoid Attenuates Disease in Simian/HIV-Challenged Macaques

Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques

"Kinoids": the basis for anticytokine immunization and their use in HIV infection

Preparation of diphtheria vaccines using highly purified toxins

Interferon α and Tat Involvement in the Immunosuppression of Uninfected T Cells and C-C Chemokine Decline in AIDS

C-C Chemokines, Pivotal in Protection against HIV Type 1 Infection

Contribution of alpha interferon (alpha IFN) to HIV-induced immunosuppression

Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients

Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals

Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia

IFNα kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS

Involvement of α-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment

Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein

Production in rabbits of high levels of anti-HIV-1 gp160 antibodies

Anti-IFNα immunization raises the IFNα-neutralizing capacity of serum — an adjuvant to antiretroviral tritherapy

Identification of CD4 and Major Histocompatibility Complex Functional Peptide Sites and Their Homology with Oligopeptides from Human Immunodeficiency Virus Type 1 Glycoprotein gp120: Role in AIDS Pathogenesis

Early and long-lasting protection from arthritis in tumour necrosis factor (TNF ) transgenic mice vaccinated against TNF

Lectin production by human T-lymphocytes

Suchergebnisse filtern